Paroxetine showed no clear difference in failure to remit at endpoint compared with sertraline (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with tianeptine (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with trazodone (moderate certainty).
Paroxetine probably leads to higher failure to remit at endpoint compared with venlafaxine (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with amisulpride (moderate certainty).
Paroxetine leads to higher failure to remit at endpoint compared with aprepitant (high certainty).
The review found no eligible studies for this question.
Paroxetine showed no clear difference in failure to remit at endpoint compared with older ADs (low certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with duloxetine (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with escitalopram (low certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with fluvoxamine (moderate certainty).
Paroxetine probably leads to higher failure to remit at endpoint compared with hypericum (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint compared with milnacipran (moderate certainty).
Paroxetine probably leads to higher failure to remit at endpoint compared with mirtazapine (moderate certainty).
Paroxetine showed no clear difference in failure to remit at endpoint HDRS compared with agomelatine (moderate certainty).